NJ Hospital's Robotic Spine System: A Leap for Patients or Tech Arms Race?

SOMERS POINT, NJ – June 25, 2026 – For the millions of people worldwide whose lives are constrained by chronic back and neck pain, the promise of a more precise, less invasive surgical solution is a powerful one. This week, that promise took a significant step forward for residents of South Jersey. Shore Medical Center, an independent community hospital, announced it has become the first in New Jersey to acquire and offer the VELYS™ Active Robotic Assistance Platform for spinal procedures, a next-generation system designed to elevate the standard of care.

The announcement places the 196-bed hospital at the forefront of a technological wave transforming operating rooms. But beyond the immediate benefits for patients, this move represents a fascinating case study in healthcare strategy, regional competition, and the complex calculus of investing in multi-million dollar medical technology.

Pioneering Precision: Inside the VELYS™ Spine Platform

At the heart of the news is the technology itself. Developed by DePuy Synthes, the orthopedics arm of Johnson & Johnson MedTech, the VELYS™ Spine platform is not just another robot. It's a sophisticated, dual-use system that combines advanced navigation with active robotic assistance. Unlike some systems that feature rigid, pre-programmed arms, VELYS™ is designed for collaboration. Its key innovation is VELYS ADAPTIVE TRACKING™ Technology, which uses a high-speed infrared camera to continuously adjust to microscopic patient movements during surgery, ensuring the surgeon’s instruments remain perfectly aligned with the pre-operative plan.

This “active robotics” approach keeps the surgeon firmly in control, allowing for manual guidance of the robotic arm, which then provides autonomous alignment for the trajectory. It’s a blend of human expertise and machine precision. The system’s dual-use capability also gives surgeons the flexibility to use it as a standalone navigation system or as a fully integrated robotic platform, tailoring the approach to the specific patient and procedure.

The goal is to enable more complex procedures to be performed through minimally invasive techniques. For the patient, this can mean smaller incisions, less damage to surrounding muscle and tissue, and a host of potential downstream benefits. As Dr. Leonard Galler, Shore Medical Center’s Chief Medical Officer, stated, the platform "enhances precision during spine surgery, allowing us to perform many procedures using minimally invasive techniques that can reduce pain and speed recovery." This translates into shorter hospital stays and a quicker return to the activities that matter most, a critical metric for both patient quality of life and healthcare efficiency.

A Strategic Play for a Community Hospital

Shore Medical Center's decision to be the first in the state to adopt this specific technology is a bold strategic move. As an independent, non-profit community hospital, it operates in a landscape often dominated by massive healthcare systems. An investment of this magnitude—robotic surgical systems typically cost between $500,000 and $1.5 million, with additional ongoing costs for maintenance and disposables—is not made lightly.

"Being the first and only hospital in New Jersey to offer the VELYS™ Spine Platform reflects our commitment to bringing leading-edge care to South Jersey," said David R. Hughes, President and CEO of Shore Medical Center. His statement underscores the dual mission here: advancing patient care and cementing the hospital’s role as a regional leader. By providing state-of-the-art treatment locally, Shore eliminates the need for patients to travel to major metropolitan centers like Philadelphia or New York for specialized procedures, a significant advantage for community health and a powerful marketing tool.

This move can be seen as a calculated play to attract top surgical talent and a patient base seeking the latest advancements. In the competitive healthcare market of New Jersey, being the first to offer a next-generation platform from a major manufacturer like Johnson & Johnson creates a distinct competitive advantage. It signals to the community, to referring physicians, and to rival institutions that Shore Medical Center is investing aggressively in its future and in its specialty service lines, particularly its Joint Commission-certified spine surgery program.

Beyond the Hype: The Realities of Robotic Surgery

While the adoption of VELYS™ is a clear win for Shore and its patients, it’s important to place it within the broader context of the robotic surgery landscape. The field is not new, but it is rapidly evolving. For years, systems like Medtronic's Mazor X and Globus Medical's ExcelsiusGPS have been the workhorses of robotic spine surgery, and many of New Jersey's larger hospital networks already have them. These systems have proven their ability to increase the accuracy of pedicle screw placement, reduce radiation exposure, and facilitate minimally invasive approaches.

The introduction of VELYS™ represents the next iteration, with a focus on surgeon control and adaptability. However, the fundamental questions surrounding robotic surgery remain. The high capital cost and per-procedure expenses raise important issues of healthcare economics. Hospitals must build a strong business case, balancing the initial investment against the potential for better outcomes, reduced complication rates, and shorter lengths of stay—all of which can lead to long-term savings in a value-based care model.

Furthermore, the surgeon remains the most critical component of any surgery. These robotic platforms are sophisticated assistants, not autonomous operators. There is a significant learning curve, and proficiency requires extensive training and experience. The success of any robotic program hinges on the skill of the surgical team using it. While most insurers cover robotic-assisted procedures when medically necessary, the higher upfront cost continues to fuel debate among healthcare policymakers and economists about cost-effectiveness and equitable access to such advanced technology.

Shore Medical Center's investment in the VELYS™ Spine platform is a powerful statement about its vision for the future of patient care in South Jersey. It highlights a commitment to technological leadership and provides local patients with access to a remarkable new tool. It also serves as a compelling example of the high-stakes, high-reward environment of modern healthcare, where strategic investments in innovation are crucial for navigating a complex and ever-changing landscape.